LANXESS to expand bladder production in Argentina
Friday, 04. February 2011 LANXESS continues to expand its activities in the growing Latin America region. The specialty chemicals company’s wholly-owned subsidiary Rhein Chemie will invest a single-digit million USD amount in its newly-acquired production site in Burzaco, Argentina.
• Subsidiary Rhein Chemie invests single-digit million amount in newly-acquired Burzaco site
• Production capacity for bladders to increase by 40 % in H2, 2011
• 20 new jobs to be created
Leverkusen, Mannheim, Buenos Aires – LANXESS continues to expand its activities in the growing Latin America region. The specialty chemicals company’s wholly-owned subsidiary Rhein Chemie will invest a single-digit million USD amount in its newly-acquired production site in Burzaco, Argentina.
Rhein Chemie plans to expand bladder production by 40 percent at the site located in the province of Buenos Aires. The new capacities will come on stream in the second half of 2011. The expansion will create 20 new positions locally.
“This investment underlines our commitment to supply our customers in the Brazilian, European and American tire industries with highly reliable bladders,” said José Sganga, General Manager of Rhein Chemie Argentina. “Beyond this investment, we are considering new facilities to manufacture bladders and polymer-bound chemicals in Brazil.”
Last month, Rhein Chemie acquired Darmex S.A. and its production sites in Argentina (Burzaco and Merlo) and Uruguay (Colonia). The acquisition means Rhein Chemie is the only producer worldwide of both bladders and release agents, representing a one-stop solution for tire manufacturers.
Bladders are used in the tires manufacturing process. A green or non-vulcanized tire is placed in a press. Once the press is shut, the internal pressure forces the green tire against the internal wall of the tire mold. This is done using a butyl rubber bladder that is then inflated under high pressure and at high temperatures to give the tire its final shape. Rhein Chemie bladders, to be sold under the brand name Rhenoshape®, have a longer life cycle thus increasing the number of tires produced about 20 percent.
Release agents are required to prevent the tire from sticking to either the bladder or the mold. For tire manufacturers, these chemicals are essential for ensuring a smooth, cost-effective production process.
The demand for release agents and bladders is expected to expand in parallel to global tire production, which is expected to grow on average by approximately five percent per year in the next ten years. The mega-trend of mobility is underpinning this growth, driven by a growing middle-class in countries such as Brazil, China and India.
In addition, an increasing number of tire companies are outsourcing their bladder production in order to optimize productivity and take advantage of the higher quality offered by bladder specialists. The size of the global bladder market is estimated at more than EUR 300 million.
Rhein Chemie develops, produces and sells additives, specialty chemicals and service products for the rubber, lubricant and plastics industries. In fiscal 2009 Rhein Chemie achieved sales of EUR 226 million and has approximately 1,000 employees worldwide. The company is headquartered in Mannheim, Germany and has production facilities in Europe, Asia and North and South America. Rhein Chemie is a wholly owned subsidiary of the specialty chemicals group LANXESS, Leverkusen, Germany.
LANXESS is a leading specialty chemicals company with sales of EUR 5.06 billion in 2009 and currently around 14,700 employees in 24 countries. The company is represented at 45 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of plastics, rubber, intermediates and specialty chemicals.
This news release contains forward-looking statements based on current assumptions and forecasts made by the management of Rhein Chemie Rheinau GmbH. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of our sole stockholder LANXESS Deutschland GmbH and the estimates given here. These factors include those discussed in LANXESS AG’s reports to the Frankfurt Stock Exchange. LANXESS AG and Rhein Chemie Rheinau GmbH assume no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Mannheim, 04. February 2011
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.